ARTICLE | Company News
airPharma, Britannia deal
November 15, 2004 8:00 AM UTC
airPharma received an exclusive global development and marketing license to AP0016 for all respiratory/pulmonary indications. The compound is a dry powder formulation of Britannia's protein-free syn...